VERMOX is a Oral Tablet, Chewable in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Mebendazole.
| Product ID | 50458-675_086f72d0-a9b6-46ea-ac0d-53a4999fa3a2 |
| NDC | 50458-675 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VERMOX |
| Generic Name | Mebendazole |
| Dosage Form | Tablet, Chewable |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-10-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208398 |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | MEBENDAZOLE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Anthelmintic [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2016-10-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208398 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-10-20 |
| Ingredient | Strength |
|---|---|
| MEBENDAZOLE | 500 mg/1 |
| SPL SET ID: | a720c424-517a-461b-8e13-6c37caf8aa3f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-675 | VERMOX | mebendazole |
| 50580-070 | VERMOX | mebendazole |
| 64896-669 | Emverm | mebendazole |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VERMOX 86870940 not registered Live/Pending |
Johnson & Johnson 2016-01-11 |
![]() VERMOX 86065978 not registered Live/Pending |
Zylera Pharmaceuticals LLC 2013-09-16 |
![]() VERMOX 85833992 not registered Dead/Abandoned |
JOHNSON & JOHNSON 2013-01-28 |
![]() VERMOX 73362222 1261438 Dead/Cancelled |
Johnson & Johnson 1982-04-29 |